Identification of vasodilators from molecular descriptors by machine learning methods
暂无分享,去创建一个
Ying Xue | Xue-Gang Yang | Yong Cong | Y. Xue | Xue-Gang Yang | Yong Cong | Ying Xue
[1] R. Czerminski,et al. Use of Support Vector Machine in Pattern Classification: Application to QSAR Studies , 2001 .
[2] Nello Cristianini,et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..
[3] Pierre Baldi,et al. Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..
[4] B. K. Park,et al. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues. , 2002, Journal of medicinal chemistry.
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[6] E. Barreiro,et al. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues. , 2005, Bioorganic & medicinal chemistry.
[7] P. Carrupt,et al. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties. , 2007, Journal of medicinal chemistry.
[8] M Pastor,et al. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] Bernard De Baets,et al. Feature subset selection for splice site prediction , 2002, ECCB.
[10] J. L. Hodges,et al. Discriminatory Analysis - Nonparametric Discrimination: Consistency Properties , 1989 .
[11] S. Vilar,et al. Quantitative Structure Vasodilatory Activity Relationship – Synthesis and “In Silico” and “In Vitro” Evaluation of Resveratrol‐Coumarin Hybrids , 2007 .
[12] R. Kurumbail,et al. Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. , 2003, Bioorganic & medicinal chemistry letters.
[13] Z R Li,et al. Prediction of genotoxicity of chemical compounds by statistical learning methods. , 2005, Chemical research in toxicology.
[14] Bernard F. Buxton,et al. Support Vector Machines in Combinatorial Chemistry , 2001 .
[15] Bernard F. Buxton,et al. Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..
[16] Robert M Califf,et al. Cardiovascular disease on a global scale: defining the path forward for research and practice. , 2007, European heart journal.
[17] J. Ross Quinlan,et al. C4.5: Programs for Machine Learning , 1992 .
[18] C W Yap,et al. Classification of a diverse set of Tetrahymena pyriformis toxicity chemical compounds from molecular descriptors by statistical learning methods. , 2006, Chemical research in toxicology.
[19] T. Liljefors,et al. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor. , 2004, Journal of molecular graphics & modelling.
[20] P. Petluru,et al. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent , 2003, Cancer Chemotherapy and Pharmacology.
[21] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[22] M. Raizada,et al. Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents , 2008, Hypertension.
[23] Z. R. Li,et al. A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor. , 2008, Journal of molecular graphics & modelling.
[24] F. Uckun,et al. Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase. , 2000, Biochemical pharmacology.
[25] Xin Chen,et al. Effect of Molecular Descriptor Feature Selection in Support Vector Machine Classification of Pharmacokinetic and Toxicological Properties of Chemical Agents , 2004, J. Chem. Inf. Model..
[26] R. Carrón,et al. Vasorelaxant activity of phthalazinones and related compounds. , 2006, Bioorganic & medicinal chemistry letters.
[27] H H Lin,et al. Prediction of factor Xa inhibitors by machine learning methods. , 2007, Journal of molecular graphics & modelling.
[28] Vipin Kumar,et al. Introduction to Data Mining , 2022, Data Mining and Machine Learning Applications.
[29] C. J. Huberty,et al. Applied Discriminant Analysis , 1994 .
[30] Takako Aizawa,et al. Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals. , 2003, Water research.
[31] L. Santana,et al. Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives. , 2002, Bioorganic & medicinal chemistry letters.
[32] Richard A. Johnson,et al. Applied Multivariate Statistical Analysis , 1983 .
[33] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[34] J. Lehmann,et al. NO donors. Part 16: investigations on structure-activity relationships of organic mononitrates reveal 2-nitrooxyethylammoniumnitrate as a high potent vasodilator. , 2007, Bioorganic & medicinal chemistry letters.
[35] L. Lazzarato,et al. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. , 2006, Journal of medicinal chemistry.
[36] H. Yu,et al. Discovering compact and highly discriminative features or combinations of drug activities using support vector machines , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.
[37] Q Xie,et al. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. , 2001, Chemical research in toxicology.
[38] Min Wang,et al. Prediction of antibacterial compounds by machine learning approaches , 2009, J. Comput. Chem..
[39] J. F. Wang,et al. Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach , 2004, J. Chem. Inf. Model..
[40] C. O'connor,et al. Depression and cardiovascular disease: mechanisms of interaction , 2003, Biological Psychiatry.
[41] F. Sanz,et al. Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. , 2005 .
[42] Ron Kohavi,et al. Wrappers for Feature Subset Selection , 1997, Artif. Intell..
[43] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[44] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[45] J E Roulston,et al. Screening with tumor markers , 2002, Molecular biotechnology.
[46] X. Chen,et al. SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence , 2003, Nucleic Acids Res..
[47] Paola Gramatica,et al. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles. , 2006, Chemical research in toxicology.
[48] Vladimir N. Vapnik,et al. The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.
[49] Christopher J. C. Burges,et al. A Tutorial on Support Vector Machines for Pattern Recognition , 1998, Data Mining and Knowledge Discovery.
[50] J. Gibbs. Mechanism-based target identification and drug discovery in cancer research. , 2000, Science.
[51] Cesare Furlanello,et al. An accelerated procedure for recursive feature ranking on microarray data , 2003, Neural Networks.
[52] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[53] P. Furet,et al. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. , 1997, Journal of medicinal chemistry.
[54] Juan J Perez,et al. Managing molecular diversity. , 2005, Chemical Society reviews.
[55] F. Messerli. Vasodilatory edema: a common side effect of antihypertensive therapy. , 2001, Current cardiology reports.
[56] Z. R. Li,et al. Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. , 2006, Journal of molecular graphics & modelling.
[57] W. Pettinger,et al. Side Effects of Vasodilator Therapy , 1988, HYPERTENSION.